Martha M. Werler, DSc

Professor, Epidemiology
Martha Werler
Talbot – T326E
View full profile at BUMC


Dr. Werler is Professor and Chair of Epidemiology. She is a perinatal epidemiologist whose NIH- and CDC- supported research includes projects on maternal serum markers of infection and abdominal wall defects; gene-environment interactions and clubfoot; medications, folic acid intake, and inheritance in relation to spina bifida; and psycho-social and cognitive outcomes in children born with craniofacial birth defects. She has published over 175 papers and book chapters; received the National Birth Defect Prevention Network Oakley Award, the Society for Pediatric and Perinatal Epidemiologic Research Mentoring Award, and the Teratology Society Fraser Award; and served on numerous NIH advisory and review boards. Dr. Werler is Director of the BU Reproductive, Perinatal, and Pediatric Epidemiology training program for pre-doctoral candidates in Epidemiology and teaches Design and Conduct of Case-Control Studies.

Other Positions

  • Chair, Epidemiology, Boston University School of Public Health


  • University of Michigan at Ann Arbor, MPH
  • Boston College, BS
  • Boston University, DSc

Classes Taught

  • SPHEP813
  • SPHEP820
  • SPHEP858
  • SPHEP911


  • Published on 11/16/2017

    Brogly SB, Hernández-Diaz S, Regan E, Fadli E, Hahn KA, Werler MM. Neonatal Outcomes in a Medicaid Population With Opioid Dependence. Am J Epidemiol. 2017 Nov 16. PMID: 29155919.

    Read at: PubMed
  • Published on 11/2/2017

    Werler MM, Parker SE. The Gastroschisis Puzzle: Where are We and What is Next? Paediatr Perinat Epidemiol. 2017 Nov; 31(6):560-562. PMID: 29096040.

    Read at: PubMed
  • Published on 11/2/2017

    Kerr SM, Parker SE, Mitchell AA, Tinker SC, Werler MM. Periconceptional maternal fever, folic acid intake, and the risk for neural tube defects. Ann Epidemiol. 2017 Dec; 27(12):777-782.e1. PMID: 29133009.

    Read at: PubMed
  • Published on 9/20/2017

    Interrante JD, Ailes EC, Lind JN, Anderka M, Feldkamp ML, Werler MM, Taylor LG, Trinidad J, Gilboa SM, Broussard CS. Risk comparison for prenatal use of analgesics and selected birth defects, National Birth Defects Prevention Study 1997-2011. Ann Epidemiol. 2017 Oct; 27(10):645-653.e2. PMID: 28993061.

    Read at: PubMed
  • Published on 9/1/2017

    Speltz ML, Wallace ER, Collett BR, Heike CL, Luquetti DV, Werler MM. Intelligence and Academic Achievement of Adolescents with Craniofacial Microsomia. Plast Reconstr Surg. 2017 Sep; 140(3):571-580. PMID: 28841618.

    Read at: PubMed
  • Published on 4/3/2017

    Fisher SC, Van Zutphen AR, Werler MM, Lin AE, Romitti PA, Druschel CM, Browne ML. Maternal Antihypertensive Medication Use and Congenital Heart Defects: Updated Results From the National Birth Defects Prevention Study. Hypertension. 2017 May; 69(5):798-805. PMID: 28373593.

    Read at: PubMed
  • Published on 2/24/2017

    Parker SE, Werler MM, Gissler M, Surcel HM. Maternal Antibodies to Chlamydia trachomatis and Risk of Gastroschisis. Birth Defects Res. 2017 May 01; 109(8):543-549. PMID: 28398639.

    Read at: PubMed
  • Published on 1/1/2017

    Speltz ML, Wallace ER, Collett BR, Heike CL, Luquetti DV, Werler MM. Intelligence and academic achievement of adolescents with craniofacial microsomia. Plastic and Reconstructive Surgery. 2017; ((in press)).

  • Published on 12/1/2016

    Brogly SB, Saia K, Hernández-Diaz S, Werler M, Sebastiani P. The comparative safety of buprenorphine versus methadone in pregnancy-what about confounding? Addiction. 2016 Dec; 111(12):2130-2131. PMID: 28075537.

    Read at: PubMed
  • Published on 11/17/2016

    Werler MM, Parker SE, Hedman K, Gissler M, Ritvanen A, Surcel HM. Maternal Antibodies to Herpes Virus Antigens and Risk of Gastroschisis in Offspring. Am J Epidemiol. 2016 Dec 15; 184(12):902-912. PMID: 27856447.

    Read at: PubMed

View 182 more publications:View full profile at BUMC

News & In the Media